This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
Delivered as a Hybrid Event
September 18-21, 2023Boston Convention and Exhibition Center

Eric Blair
Chief Commercial Officer at Andelyn Biosciences

Profile

Eric brings his 24+ years of experience to his role as Chief Commercial Officer (CCO) at Andelyn Biosciences.  Most recently Eric was the CCO of Argonaut Manufacturing Services leading the commercial function including sales, marketing, corporate strategy, strategic partnerships, product/service development, and commercial development.   Under his 3-year tenure, Eric and his peers guided the explosive growth of the company, and the Argonaut Board of Directors called the work Eric did as “transformational” for it’s clients, colleagues, and the company.  

Eric has served clients and grown strategic relationships over the past 7+ years in the CDMO market.   Eric previously served as Chief Commercial Officer at Argonaut Manufacturing Services, Global Vice President of Sales at Metabolon, and he held various leadership roles through his 15-year career at Applied Biosystems-Life Technologies-Thermo Fisher Scientific.  He also spent 2 years running an academic Genomics laboratory at the Institute for Biology, Biotechnology, and Bioinformatics (IB3), and started his career working for Craig Venter’s The Institute for Genomic Research (TIGR, now JCVI).  

Eric holds undergraduate degrees in Biology and Spanish from the University of California, Santa Barbara (UCSB) and University of Alcala de Henares (Madrid, Spain), and a Master’s degree in Business Administration from Regis University.  He is a strategic advisor to startup biotechnology and biopharma companies, has served on multiple scientific and business panels, and is a co-author on numerous scientific and business publications.  

Agenda Sessions

  • Future Perspectives on the Cell and Gene Therapy Industry

    9:20am